Try it
General Medicine · Haematology: CLL versus mantle cell lymphoma
Sample itemA 66-year-old man has generalised painless lymphadenopathy and a lymphocyte count of 55,000 per microlitre, with smudge cells on the film. Flow cytometry shows CD19-positive, CD5-positive monoclonal B cells. Which additional finding best distinguishes chronic lymphocytic leukaemia from mantle cell lymphoma?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Expression of CD23
Both chronic lymphocytic leukaemia and mantle cell lymphoma co-express CD5 and CD19. CLL is typically CD23-positive with dim surface immunoglobulin and weak CD20, while mantle cell lymphoma is CD23-negative with cyclin D1 overexpression from t(11;14). CD10 positivity points to follicular, Burkitt or diffuse large B-cell lymphoma of germinal centre origin.
Option by option
A. Nuclear cyclin D1 overexpression
Cyclin D1 overexpression is the hallmark of mantle cell lymphoma, which would argue against CLL.
B. Expression of CD23 (correct)
Correct. CD23 positivity together with CD5 supports CLL, since mantle cell lymphoma is CD23-negative.
C. Expression of CD10
CD10 is characteristic of germinal centre lymphomas, not of CLL or mantle cell lymphoma.
D. Expression of CD5
CD5 is found in both diseases and cannot separate them.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…